IL84275A - Pharmaceutical composition comprising erythropoietin for treatment of iron overload disorders - Google Patents
Pharmaceutical composition comprising erythropoietin for treatment of iron overload disordersInfo
- Publication number
- IL84275A IL84275A IL84275A IL8427587A IL84275A IL 84275 A IL84275 A IL 84275A IL 84275 A IL84275 A IL 84275A IL 8427587 A IL8427587 A IL 8427587A IL 84275 A IL84275 A IL 84275A
- Authority
- IL
- Israel
- Prior art keywords
- erythropoietin
- treatment
- pharmaceutical composition
- iron overload
- iron
- Prior art date
Links
- 102000003951 Erythropoietin Human genes 0.000 title abstract 2
- 108090000394 Erythropoietin Proteins 0.000 title abstract 2
- 206010065973 Iron Overload Diseases 0.000 title abstract 2
- 208000037265 diseases, disorders, signs and symptoms Diseases 0.000 title abstract 2
- 229940105423 erythropoietin Drugs 0.000 title abstract 2
- OXCMYAYHXIHQOA-UHFFFAOYSA-N potassium;[2-butyl-5-chloro-3-[[4-[2-(1,2,4-triaza-3-azanidacyclopenta-1,4-dien-5-yl)phenyl]phenyl]methyl]imidazol-4-yl]methanol Chemical compound [K+].CCCCC1=NC(Cl)=C(CO)N1CC1=CC=C(C=2C(=CC=CC=2)C2=N[N-]N=N2)C=C1 OXCMYAYHXIHQOA-UHFFFAOYSA-N 0.000 title abstract 2
- 239000008194 pharmaceutical composition Substances 0.000 title 1
- XEEYBQQBJWHFJM-UHFFFAOYSA-N Iron Chemical compound [Fe] XEEYBQQBJWHFJM-UHFFFAOYSA-N 0.000 abstract 4
- 241000124008 Mammalia Species 0.000 abstract 3
- 210000003743 erythrocyte Anatomy 0.000 abstract 2
- 229910052742 iron Inorganic materials 0.000 abstract 2
- 210000002966 serum Anatomy 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/04—Peptides having up to 20 amino acids in a fully defined sequence; Derivatives thereof
- A61K38/08—Peptides having 5 to 11 amino acids
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides
- A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- A61K38/17—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- A61K38/18—Growth factors; Growth regulators
- A61K38/1816—Erythropoietin [EPO]
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P7/00—Drugs for disorders of the blood or the extracellular fluid
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Engineering & Computer Science (AREA)
- Pharmacology & Pharmacy (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Behavior & Ethology (AREA)
- General Health & Medical Sciences (AREA)
- Epidemiology (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Gastroenterology & Hepatology (AREA)
- Immunology (AREA)
- Zoology (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Hematology (AREA)
- Diabetes (AREA)
- Obesity (AREA)
- Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
- Medicines Containing Material From Animals Or Micro-Organisms (AREA)
- Treatment Of Water By Oxidation Or Reduction (AREA)
- Manufacture Of Iron (AREA)
- Chemical Treatment Of Metals (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Treatment Of Water By Ion Exchange (AREA)
- Peptides Or Proteins (AREA)
- Compounds Of Iron (AREA)
- Hydrogen, Water And Hydrids (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/933,495 US5013718A (en) | 1986-11-21 | 1986-11-21 | Method for treating iron overload using EPO |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| IL84275A true IL84275A (en) | 1993-04-04 |
Family
ID=25464076
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| IL84275A IL84275A (en) | 1986-11-21 | 1987-10-25 | Pharmaceutical composition comprising erythropoietin for treatment of iron overload disorders |
Country Status (16)
| Country | Link |
|---|---|
| US (1) | US5013718A (el) |
| EP (1) | EP0269394B1 (el) |
| JP (1) | JPH0692316B2 (el) |
| KR (1) | KR950009100B1 (el) |
| AT (1) | ATE68352T1 (el) |
| AU (1) | AU602028B2 (el) |
| CA (1) | CA1322165C (el) |
| DE (1) | DE3773852D1 (el) |
| DK (1) | DK167650B1 (el) |
| ES (1) | ES2039252T3 (el) |
| GR (1) | GR3003254T3 (el) |
| IE (1) | IE60865B1 (el) |
| IL (1) | IL84275A (el) |
| NZ (1) | NZ222432A (el) |
| PT (1) | PT86187B (el) |
| WO (1) | WO1988003808A1 (el) |
Families Citing this family (21)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JP2858752B2 (ja) * | 1987-04-10 | 1999-02-17 | オーソ・フアーマシユーチカル・コーポレーシヨン | 正常な哺乳動物のヘマトクリツト値の増大方法 |
| US5766897A (en) * | 1990-06-21 | 1998-06-16 | Incyte Pharmaceuticals, Inc. | Cysteine-pegylated proteins |
| US6012450A (en) * | 1993-01-29 | 2000-01-11 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
| US5354934A (en) * | 1993-02-04 | 1994-10-11 | Amgen Inc. | Pulmonary administration of erythropoietin |
| ES2206521T3 (es) | 1994-11-03 | 2004-05-16 | Roche Diagnostics Gmbh | Utilizacion de la eritropoyetina en el tratamiento de artritis reumatoide. |
| EP0817655B1 (en) | 1995-03-31 | 2004-05-19 | Aradigm Corporation | Intrapulmonary delivery of hematopoietic drug |
| TW586933B (en) * | 1996-06-20 | 2004-05-11 | Chugai Pharmaceutical Co Ltd | Compositions for treating liver-complaints using EPO |
| US5952226A (en) * | 1996-11-05 | 1999-09-14 | Modex Therapeutiques | Hypoxia responsive EPO producing cells |
| AR019025A1 (es) | 1998-04-09 | 2001-12-26 | Roche Diagnostics Gmbh | Uso de eritropoyetina en bajas dosis para producir un preparado farmaceutico para el tratamiento de hemocromatosis, preparado farmaceutico combinadoutilizado segun dicho uso y envase farmaceutico unitario que contiene al referido preparado farmaceutico combinado |
| EP0965349A1 (de) * | 1998-06-18 | 1999-12-22 | Roche Diagnostics GmbH | Verwendung von Erythropoietin zur Behandlung von Hämochromatosen |
| US6210924B1 (en) | 1998-08-11 | 2001-04-03 | Amgen Inc. | Overexpressing cyclin D 1 in a eukaryotic cell line |
| DE19857609A1 (de) * | 1998-12-14 | 2000-06-15 | Hannelore Ehrenreich | Verwendung von Erythropoietin zur Behandlung von cerebralen Ischämien des Menschen |
| AU3269101A (en) * | 1999-11-12 | 2001-06-06 | James C. Barton | Diagnostic test for hemochromatosis |
| US7160855B2 (en) * | 2002-03-14 | 2007-01-09 | Children's Hospital & Research Center At Oakland | Enhancement of iron chelation therapy |
| DE10234192B4 (de) | 2002-07-26 | 2009-11-26 | Epoplus Gmbh Co.Kg | Verwendung von Erythropoetin |
| CA2498319A1 (en) * | 2002-09-09 | 2004-03-18 | Nautilus Biotech | Rational evolution of cytokines for higher stability, the cytokines and encoding nucleic acid molecules |
| EP2120998B1 (en) | 2006-11-28 | 2013-08-07 | HanAll Biopharma Co., Ltd. | Modified erythropoietin polypeptides and uses thereof for treatment |
| US10694962B2 (en) | 2011-06-13 | 2020-06-30 | Cedars-Sinai Medical Center | Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage |
| US10694961B2 (en) * | 2011-06-13 | 2020-06-30 | Cedaris-Sinai Medical Center | Assessment of iron deposition post myocardial infarction as a marker of myocardial hemorrhage |
| FR3037592B1 (fr) | 2015-06-18 | 2017-06-09 | Michelin & Cie | Pneumatique pourvu d'une bande de roulement comprenant un elastomere dienique et un systeme d'elastomeres thermoplastiques |
| JP2023544727A (ja) | 2020-10-02 | 2023-10-25 | ケロス セラピューティクス インコーポレイテッド | アクチビン受容体ｉｉ型バリアントの使用方法 |
Family Cites Families (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPH0686480B2 (ja) * | 1983-02-21 | 1994-11-02 | 雪印乳業株式会社 | エリスロポエチン製造用モノクローナル抗体 |
| US4703008A (en) * | 1983-12-13 | 1987-10-27 | Kiren-Amgen, Inc. | DNA sequences encoding erythropoietin |
| NZ210501A (en) * | 1983-12-13 | 1991-08-27 | Kirin Amgen Inc | Erythropoietin produced by procaryotic or eucaryotic expression of an exogenous dna sequence |
| US4667016A (en) * | 1985-06-20 | 1987-05-19 | Kirin-Amgen, Inc. | Erythropoietin purification |
-
1986
- 1986-11-21 US US06/933,495 patent/US5013718A/en not_active Expired - Lifetime
-
1987
- 1987-10-19 WO PCT/US1987/002673 patent/WO1988003808A1/en not_active Ceased
- 1987-10-19 AU AU81794/87A patent/AU602028B2/en not_active Expired
- 1987-10-19 KR KR1019880700864A patent/KR950009100B1/ko not_active Expired - Lifetime
- 1987-10-25 IL IL84275A patent/IL84275A/xx not_active IP Right Cessation
- 1987-11-03 NZ NZ222432A patent/NZ222432A/xx unknown
- 1987-11-18 CA CA000552139A patent/CA1322165C/en not_active Expired - Lifetime
- 1987-11-18 IE IE311387A patent/IE60865B1/en not_active IP Right Cessation
- 1987-11-19 JP JP62293071A patent/JPH0692316B2/ja not_active Expired - Lifetime
- 1987-11-20 PT PT86187A patent/PT86187B/pt active IP Right Revival
- 1987-11-20 EP EP87310300A patent/EP0269394B1/en not_active Expired - Lifetime
- 1987-11-20 ES ES198787310300T patent/ES2039252T3/es not_active Expired - Lifetime
- 1987-11-20 DE DE8787310300T patent/DE3773852D1/de not_active Expired - Lifetime
- 1987-11-20 AT AT87310300T patent/ATE68352T1/de not_active IP Right Cessation
-
1988
- 1988-07-21 DK DK407488A patent/DK167650B1/da not_active IP Right Cessation
-
1991
- 1991-12-02 GR GR91401882T patent/GR3003254T3/el unknown
Also Published As
| Publication number | Publication date |
|---|---|
| CA1322165C (en) | 1993-09-14 |
| KR890700032A (ko) | 1989-03-02 |
| DK407488D0 (da) | 1988-07-21 |
| GR3003254T3 (en) | 1993-02-17 |
| EP0269394B1 (en) | 1991-10-16 |
| IE873113L (en) | 1988-05-21 |
| AU602028B2 (en) | 1990-09-27 |
| PT86187A (en) | 1987-12-01 |
| PT86187B (pt) | 1990-11-07 |
| EP0269394A3 (en) | 1988-09-14 |
| KR950009100B1 (ko) | 1995-08-14 |
| JPS63159322A (ja) | 1988-07-02 |
| DK167650B1 (da) | 1993-12-06 |
| ATE68352T1 (de) | 1991-11-15 |
| AU8179487A (en) | 1988-06-16 |
| IE60865B1 (en) | 1994-08-24 |
| WO1988003808A1 (en) | 1988-06-02 |
| US5013718A (en) | 1991-05-07 |
| EP0269394A2 (en) | 1988-06-01 |
| DK407488A (da) | 1988-07-21 |
| DE3773852D1 (de) | 1991-11-21 |
| NZ222432A (en) | 1990-07-26 |
| JPH0692316B2 (ja) | 1994-11-16 |
| ES2039252T3 (es) | 1993-09-16 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| NZ222432A (en) | Composition of erythropoietin for treating iron overload in mammals | |
| PT85285A (en) | Process for producing il-6 and of pharmaceutical compositions containing the same | |
| MY101209A (en) | Production of m-csf. | |
| EP0177137A3 (en) | White blood cell differentiation composition and method | |
| PT82619A (en) | Process for the preparation of a therapeutic composition for the local treatment of dandruff seborrrheic dermatitis and psoriasis | |
| GR3002880T3 (en) | Cosmetic composition | |
| IE791001L (en) | Acyl-carnitines with triglycerides | |
| PT87197A (pt) | Processo para preparacao de agentes terapeuticos eritropoietina | |
| AU1553388A (en) | Treatment of diabetes | |
| OA07002A (fr) | Dérivé de la pyrrolidine, sa préparation et ses utilisations thérapeutiques pour le traitement de l'insuffisance cérébrale. | |
| EP0388799A3 (en) | Use of human interferon-beta for stimulation of erythropoieses | |
| EP0306191A3 (en) | 2,3-dihydroergolines for serotonergic function enhancement | |
| OA09455A (fr) | Nouveaux polyols furanniques, utilisation de ceux-ci comme polyols dans la formation de polyuréthannes, polyuréthannes ainsi obtenus et leur procédé de préparation. | |
| IE820151L (en) | Treating shock using meptazinol | |
| PT80214A (en) | Process for the preparation of a pharmaceutical composition containing 9alpha,11beta-dichloro 16alpha-methyl 21-oxycarbonyldicyclohexyl-methyloxi-pregne-1,4-diene 3,20-dione as active agent and an inert product as excipient appropriate to permit r said composition to be used in the rectum or colon | |
| EP0202778A3 (en) | Use of (S)-2-amino-5-hydroxy-4-oxopentanoic acid for the preparation of a medicament for the treatment of systemic mycosis | |
| JPS6442470A (en) | Guanidinecarboxylic acid esters, manufacture and medicinal composition | |
| FR2616430B1 (fr) | Nouveaux diesters de l'acide azelaique, leur procede de preparation, les compositions topiques les contenant et leur utilisation dans le traitement de l'acne | |
| HUT45897A (en) | Process for production of medicines with big acid-fixing capacity, prolonged in time effect, increased bioutilty, neutralizing gastric acid | |
| UA7216A1 (uk) | Спосіб одержання похідних 12-аміно-пірідазіно[4', 5':3,4]-пірроло[2,1-а] ізохіноліна або їх фізіологічно переносимих кислотно-аддітивних солей | |
| IT8421682U1 (it) | Pressa per l'applicazione di puntali al tomaio nella fabbricazione di calzature. | |
| MA19564A1 (fr) | Derives de la pyrrolidine, sa preparation et ses utilisations therapeutiques pour le traitement de l'insuffisance cerebrale | |
| AU7931487A (en) | Therapeutic treatment of abnormal cell growth with follicle regulatory protein | |
| BG52067B2 (en) | Antihypoxic and brain-protection antidote composition |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| KB | Patent renewed | ||
| EXP | Patent expired |